ANGIODYNAMICS INC - 8-K Filing

AngioDynamics reports Q1 FY2027 results with Med Tech segment growth and announces new CEO (Items: 2.02 of this Form 8-K (including Exhibit 99, 7.01 of this Form 8-K (including Exhibit 99)

SEC EDGAR ·

Tickers: $ANGO

Read the full article at SEC EDGAR

More Regulatory news